Check out your Company Bowl for anonymous work chats.
We are honored to receive two IDEA awards – a Bronze in the health category and a People’s Choice for the design of Verily Retinal Camera! This prestigious achievement reflects our team’s dedication to building tools that advance precision health for all. The intuitive design of the Verily Retinal Camera enables greater access to precision retinal imaging for patients by conducting them in convenient locations, such as primary care settings.
Happy 8th birthday, Verily! Eight years ago, Verily was born out of Google X, the moonshot factory, with the aim of transforming healthcare. In 2016, we were founded as Verily Life Sciences, an Alphabet Inc. company. Since that time, Verily has evolved as a precision health tech company, focused on research, care, and health financing. Across all that we do, we’re helping to close the gap between research and care by creating new tools to accelerate evidence generation, products to enable more personalized care, and approaches that make costs more predictable. Cheers to 8 years!
Big news! Verily Retinal Camera won two honorable mentions in Fast Company’s 2023 Innovation by Design Awards - Best Design North America and Health categories. We are proud to be recognized alongside designers and businesses who are solving the problems of today and tomorrow. See the full list of #FCDesignAwards winners: https://lnkd.in/ePbEBrST Learn about Verily Retinal Service!
The National Academies of Sciences, Engineering, and Medicine published a framework and recommendations, co-authored by Amy Abernethy, Verily's President of Product Development & Chief Medical Officer for addressing equity issues across the innovation ecosystem to ensure medical advancements work for all people. Fast-paced technological innovation has the potential to transform health and medicine, but it also raises important social and ethical concerns. This report is an important step in addressing this complexity.
We are proud to announce a new strategic partnership with OneOncology to accelerate clinical trials and advance cancer research. Our clinical trial management software (CTMS) SignalPath will be integrated across OneOncology Research Network sites, enabling improved infrastructure, streamlined regulatory processes, and increased collaboration with sponsors. “We can help enhance our partners’ clinical trial programs, which ultimately better democratizes clinical trials, and improves health equity,” said Dr. Davey Daniel, Chief Medical Officer, OneOncology.
"Verily Hires Former Apple Health Leader Andrew Trister as Chief Scientific Officer" - We are excited to announce that Andrew Trister, an oncologist and veteran of big technology companies and research, has joined Verily as our new CSO. Trister will lead Verily’s population health initiatives, including public health solutions like the company’s ongoing work to combat disease-carrying mosquito populations and a program that helps wastewater treatment plants monitor for pathogens. Trister's focus on public health will build on his recent role as a deputy director at the Bill and Melinda Gates Foundation, where he led digital health.
Together with L'Oréal, we are excited to announce the launch of the “My Skin & Hair Journey,” a multi-year study that will help researchers better understand the many complex factors that contribute to skin and hair health over time. The registry is now open for enrollment to US self-identifying women between the ages of 18-70 from various ethnicities and social backgrounds. “This program combines L’Oréal’s deep scientific knowledge of beauty with Verily’s comprehensive technology and clinical science capabilities. Through this multifaceted partnership, we aim to bring meaningful innovation to consumers and leverage data to deliver improved precision skin and hair health outcomes.” - Stephen Gillett, Verily CEO #PrecisionHealth #HealthTech #SkinHealth
Today we announced the appointment of Laura O'Donnell as our new General Counsel. She joins us from McKesson where she was SVP, Chief Compliance Officer. Welcome to Verily, Laura! Read the news in Bloomberg Law:
Today at Viva Technology, Amy Abernethy, our President of Product Development and Chief Medical Officer, and Nicolas HIERONIMUS, CEO of L'Oréal, talked on stage about our strategic partnership and additional research opportunities. Together we aim to understand the biological, clinical, and environmental factors that impact skin and hair health and beauty to deliver real and meaningful innovation. “What we found in L’Oreal is a partner with a shared passion for this opportunity to pioneer new research approaches, and a commitment to driving forward science to benefit consumers.” - Amy Abernethy
There is massive potential for using AI in the health and wellbeing industry. For startups looking to scale their business with the best of Google tools and resources, apply to the Google for Startups Growth Academy: AI for Health. Learn more 👇
